Drug Research
Drug Discovery & Development

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
61-75 of 4547 results
SalvaRx, Immunova establish new JV firm Saugatuck Therapeutics
By PBR Staff Writer
SalvaRx has signed an agreement with Immunova to create a new joint venture (JV) firm Saugatuck Therapeutics.
Drug Research > Drug Discovery & Development > News
Landos Biopharma raises $10m in series A financing
Landos Biopharma, an emerging biopharmaceutical company focused on developing improved treatments for autoimmune diseases, announced that it has raised $10m in a series A financing led by life sciences investment management firm Perceptive Advisors, which will serve as its exclusive investor for the Series A round.
Drug Research > Drug Discovery & Development > News
MilliporeSigma opens China's first end-to-end biodevelopment center in Shanghai
MilliporeSigma announced the opening of its first BioReliance end-to-end biodevelopment center in the Asia Pacific (APAC) region.
Drug Research > Drug Discovery & Development > News
GSK, AstraZeneca, Labcyte form alliance to develop acoustic mass spectrometry
Labcyte announced that GSK has joined its consortium with AstraZeneca to combine acoustic liquid dispensing technology from Labcyte with Mass Spectrometry (MS) for use in high throughput small molecule screening and other drug discovery applications.
Drug Research > Drug Discovery & Development > News
Ultragenyx proposes to acquire Dimension Therapeutics
By PBR Staff Writer
Ultragenyx Pharmaceutical has made a proposal to acquire all of the outstanding shares of common stock of Dimension Therapeutics for $5.50 per share, or approximately $138m, in cash at close to be effectuated via a tender offer.
Drug Research > Drug Discovery & Development > News
Mustang Bio announces expansion of CAR T pipeline into CD20-directed immunotherapies
Mustang Bio, a Fortress Biotech company, has announced the expansion of its pipeline of CAR T therapies into CD20-directed immunotherapies.
Drug Research > Drug Discovery & Development > News
BMS to use Halozyme’s Enhanze technology to develop immuno-oncology medicines
By PBR Staff Writer
Bristol-Myers Squibb (BMS) has partnered with Halozyme Therapeutics for the development of immuno-oncology medicines.
Drug Research > Drug Discovery & Development > News
Berkeley Lights, Bayer partner for cell line development and antibody discovery
Berkeley Lights (BLI), a company dedicated to bringing to market transformational platforms for bio-pharmaceutical processes, has announced a strategic project with Bayer, focused on the innovation and acceleration of cell line development, antibody discovery, and research.
Drug Research > Drug Discovery & Development > News
Inotek Pharmaceuticals announces merger deal with Rocket Pharmaceuticals
Inotek Pharmaceuticals announced that it has entered into a definitive merger agreement with US-based gene therapy company Rocket Pharmaceuticals.
Drug Research > Drug Discovery & Development > News
Summit Therapeutics awarded BARDA contract to develop Ridinilazole for CDI
Summit Therapeutics announces that the Biomedical Advanced Research and Development Authority (BARDA), an agency of the US government's Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response, has awarded Summit a contract worth up to $62m.
Drug Research > Drug Discovery & Development > News
HitGen, Takeda enter DNA-encoded library based drug discovery research collaboration
HitGen announced that the company has entered into a research collaboration with Takeda Pharmaceutical Company to discover novel small molecule leads for multiple targets in Takeda’s therapeutic areas of interest.
Drug Research > Drug Discovery & Development > News
Janssen scraps hepatitis C development program
By PBR Staff Writer
Janssen Sciences Ireland UC has scrapped its ongoing hepatitis C development program citing the growing number of therapies available for treating the disease effectively.
Drug Research > Drug Discovery & Development > News
Boehringer Ingelheim, Gubra to develop next generation obesity treatments
Boehringer Ingelheim and Gubra announce a collaboration and license agreement for the development of novel peptide compounds to treat obesity.
Drug Research > Drug Discovery & Development > News
European Investment Bank grants €75m funding for Evotec
Evotec and the European Investment Bank (EIB) announced that the EIB has granted Evotec an unsecured loan facility of up to €75m to support Evotec's Innovate strategy.
Drug Research > Drug Discovery & Development > News
GSK exercises option on phase I/II NY-ESO T-cell therapy
GSK announced that it has exercised the option to obtain an exclusive global license from Adaptimmune for an investigational SPEAR T-cell receptor therapy targeting NY-ESO-1 (GSK3377794).
Drug Research > Drug Discovery & Development > News
61-75 of 4547 results